Biovalence Technologies
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.biovalence.netRevenue
<$5 MillionIndustry
About Biovalence Technologies
Biovalence Technologies Org Chart
Is Biovalence Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Biovalence Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Biovalence Technologies had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Biovalence Technologies recently announced quarterly report
Funding: Get notified immidiatlly once Biovalence Technologies has new funding data
Check if Biovalence Technologies has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Biovalence Technologies
Check out if Biovalence Technologies is spiking on competitors!
Product Launch: Get notified when Biovalence Technologies launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Biovalence Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biovalence Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biovalence Technologies.
Biovalence Technologies Tech Stack
A closer look at the technologies used by Biovalence Technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biovalence Technologies
Biovalence Technologies specializes in the development of broad-spectrum antivirals, including those targeting pandemic viruses such as SARS-CoV-2. Their flagship product, RetroMAD1, is designed to inhibit the replication of COVID-19. The company aims to provide innovative solutions that contribute to saving lives during health crises. Their intend... Read More